Clinical Trial Update: A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated) [Phase 4]

View source ↗

Summary

This completed Phase 4 trial evaluated adding heparin to drotrecogin alfa (activated) therapy in severe sepsis. The study aimed to assess safety and potential c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Drotrecogin alfa (activated) (drotrecogin alfa (activated))
• Heparin (unfractionated heparin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Sepsis | Phase 4 | Status: COMPLETED